WMS Group LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 149,855 shares of the company’s stock, valued at approximately $4,255,000. Invesco Nasdaq Biotechnology ETF accounts for about 5.4% of WMS Group LLC’s portfolio, making the stock its 4th largest position. WMS Group LLC owned about 5.97% of Invesco Nasdaq Biotechnology ETF as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. LPL Financial LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter worth about $1,220,000. Independent Advisor Alliance acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter worth about $653,000. GeoWealth Management LLC acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 3rd quarter worth about $451,000. Orion Porfolio Solutions LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth approximately $392,000. Finally, CreativeOne Wealth LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth approximately $286,000.
Invesco Nasdaq Biotechnology ETF Price Performance
Shares of IBBQ opened at $29.98 on Friday. The stock has a 50 day moving average price of $29.49 and a 200 day moving average price of $29.14. The company has a market capitalization of $67.75 million, a price-to-earnings ratio of 17.03 and a beta of 0.62. Invesco Nasdaq Biotechnology ETF has a 52-week low of $20.67 and a 52-week high of $30.50.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Further Reading
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- MarketBeat Week in Review – 06/15 – 06/19
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
